Oncolytics Biotech Inc. (ONCY)

[onco_investor]

Background on Dr. Miguel A. Villalona-Calero M.D.



Holds the Dorothy M. Davis Chair in Cancer Research at Ohio State University

http://medicalcenter.osu.edu/mediaroom/discovery/archive/2010/10/22/latest-news-on-endowed-chairs-and-professorships-2.aspx

Dr. Miguel Villalona-Calero is an internationally recognized expert in experimental therapeutics and lung cancer. He directs Ohio State’s Solid Tumor Experimental Therapeutics program. He also is director of the new Division of Medical Oncology, which will be instrumental in the growth of the cancer program at Ohio State. He is a National Cancer Institute-funded scholar and a member of its Investigational Drug Steering Committee. He has also been involved in several significant national scientific committees for the American Society for Clinical Oncology, the American Association for Cancer Research and the National Cancer Institute.

Namesake: Dorothy and William Davis were lifelong supporters of The Ohio State University. In 1987, Dorothy established The Dorothy M. Davis Chair in Cancer Research to support a scientist with significant achievements in cancer research at Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. Davis was vitally interested in the future of the University, medical research and higher education.

Also much much more at:
https://pro.osu.edu/profiles/villalona.1/


A455A Starling Loving Hall
320 W 10th Ave
Columbus, OH 43210

Phone: [phone]
Fax: [phone]

Email: [e-mail]
URL: http://internalmedicine.osu.edu/hemonc/879.cfm

Current OSU Appointments
Professor, Medical Oncology
Professor, Pharmacology

Abstracts and Short Entries

Villalona-Calero M, Lam E, Otterson G, Zhao W, Donthireddy K, Thurmond J, Hade E, Pennington J, Mettinger K, Coffey M. 2011. Phase II Study of Reovirus with Paclitaxel (P) and Carboplatin (C) in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Who Have Kras or EGFR-Activated Tumors [Abstract]. Proceedings of the 14th World Conference on Lung Cancer: Journal of Thoracic Oncology. (July) [Peer Reviewed] (Formally Accepted)